Jayne Gershkowitz, SVP, Chief Patient Advocate at AMICUS THERAPEUTICS INC (FOLD), sold 10,649 shares at $13.97 ($149K) on 2015-07-01, disclosed to the SEC on 2015-07-01.
Scheduled sale ($149k) by SVP, Chief Patient Advocate under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2014-08-29 | $35K | — | Filing → |
| FOLD | BUY | 2014-08-29 | $35K | — | Filing → |
| FOLD | SELL | 2014-08-26 | $30K | — | Filing → |